Aug 14, 2024 | Defective Drugs, Defective Product, Medical News, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
Ozempic, a medication primarily used to manage type 2 diabetes, has garnered significant attention due to its ability to help control blood sugar levels and promote weight loss. However, like many pharmaceuticals, Ozempic comes with potential side effects. Among...
Aug 2, 2024 | Defective Drugs, Defective Product, Medical News, Ozempic Injury, Ozempic Lawsuit, Personal Injury
Ozempic (semaglutide) is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes. Approved by the U.S. Food and Drug Administration (FDA) in 2017, Ozempic belongs to a class of drugs known as GLP-1 receptor agonists....
Jul 23, 2024 | Defective Drugs, Personal Injury, Product Liability
Ozempic, a medication produced by Novo Nordisk, has garnered significant attention not just for its effectiveness in treating type 2 diabetes, but also due to a spate of consumer lawsuits. The medication, which contains the active ingredient semaglutide, has become...
Jul 8, 2024 | Defective Drugs, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
A recent study suggests that individuals using Ozempic or Wegovy may face a higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare form of eye stroke causing sudden vision loss. Despite this, doctors advise that these medications...
Jul 1, 2024 | Mass Tort News, Multidistrict Litigation, Personal Injury, Product Liability
At Kherkher Garcia, our national mass tort attorneys consistently monitor and track developments in various mass tort cases, including class action MDLs pending in federal courts. We observe the volume of new cases filed or transferred into each MDL, identify trends...
